Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 189

1.

Decreased in vitro production of interferon-gamma and interleukin-2 in whole blood of patients with schizophrenia during treatment.

Arolt V, Rothermundt M, Wandinger KP, Kirchner H.

Mol Psychiatry. 2000 Mar;5(2):150-8.

PMID:
10822342
2.

Soluble interleukin-2 receptor levels correlated with positive symptoms during quetiapine treatment in schizophrenia-spectrum disorders.

Igue R, Potvin S, Bah R, Stip E, Bouchard RH, Lipp O, Gendron A, Kouassi E.

Prog Neuropsychopharmacol Biol Psychiatry. 2011 Aug 15;35(7):1695-8. doi: 10.1016/j.pnpbp.2011.05.011. Epub 2011 May 24.

PMID:
21627977
3.

Investigation of serum cytokine levels and cytokine production in whole blood cultures of paranoid schizophrenic patients.

Kamińska T, Wysocka A, Marmurowska-Michalowska H, Dubas-Slemp H, Kandefer-Szerszeń M.

Arch Immunol Ther Exp (Warsz). 2001;49(6):439-45.

PMID:
11814238
4.

Cytokine profiles in schizophrenic patients treated with risperidone: a 3-month follow-up study.

Cazzullo CL, Sacchetti E, Galluzzo A, Panariello A, Adorni A, Pegoraro M, Bosis S, Colombo F, Trabattoni D, Zagliani A, Clerici M.

Prog Neuropsychopharmacol Biol Psychiatry. 2002 Jan;26(1):33-9.

PMID:
11853116
5.

Cytokine production in unmedicated and treated schizophrenic patients.

Rothermundt M, Arolt V, Leadbeater J, Peters M, Rudolf S, Kirchner H.

Neuroreport. 2000 Oct 20;11(15):3385-8.

PMID:
11059907
6.

Increased production of interleukin-2 (IL-2) but not soluble interleukin-2 receptors (sIL-2R) in unmedicated patients with schizophrenia and schizophreniform disorder.

O'Donnell MC, Catts SV, Ward PB, Liebert B, Lloyd A, Wakefield D, McConaghy N.

Psychiatry Res. 1996 Dec 20;65(3):171-8.

PMID:
9029665
7.

Monocytic, Th1 and th2 cytokine alterations in the pathophysiology of schizophrenia.

Na KS, Kim YK.

Neuropsychobiology. 2007;56(2-3):55-63. Epub 2007 Nov 23.

PMID:
18037815
8.

Reduced production of interferon-gamma but not interleukin-10 in bipolar mania and subsequent remission.

Su KP, Leu SJ, Yang YY, Shen WW, Chou YM, Tsai SY.

J Affect Disord. 2002 Sep;71(1-3):205-9. Erratum in: J Affect Disord. 2003 Feb;73(3):299..

PMID:
12167518
9.

Immune-inflammatory markers in schizophrenia: comparison to normal controls and effects of clozapine.

Maes M, Meltzer HY, Bosmans E.

Acta Psychiatr Scand. 1994 May;89(5):346-51.

PMID:
8067274
10.

The influence of typical and atypical neuroleptic drugs in the production of interleukin-2 and interferon-gamma in vitro.

Rudolf S, Peters M, Rothermundt M, Arolt V, Kirchner H.

Neuropsychobiology. 2002;46(4):180-5.

PMID:
12566934
11.
12.

Production of interferon-gamma in families with multiple occurrence of schizophrenia.

Arolt V, Weitzsch C, Wilke I, Nolte A, Pinnow M, Rothermundt M, Kirchner H.

Psychiatry Res. 1997 Feb 7;66(2-3):145-52.

PMID:
9075278
13.

Immunological dysfunction in schizophrenia: a systematic approach.

Rothermundt M, Arolt V, Weitzsch C, Eckhoff D, Kirchner H.

Neuropsychobiology. 1998;37(4):186-93.

PMID:
9648126
14.

The relevance of peripheral blood T-helper 1 and 2 cytokine pattern in the evaluation of patients with mycosis fungoides and Sézary syndrome.

Papadavid E, Economidou J, Psarra A, Kapsimali V, Mantzana V, Antoniou C, Limas K, Stratigos A, Stavrianeas N, Avgerinou G, Katsambas A.

Br J Dermatol. 2003 Apr;148(4):709-18.

PMID:
12752128
16.

[Effect of clozapine and risperidone on serum cytokine levels in patients with first-episode paranoid schizophrenia].

Lü LX, Guo SQ, Chen W, Li Q, Cheng J, Guo JH.

Di Yi Jun Yi Da Xue Xue Bao. 2004 Nov;24(11):1251-4. Chinese.

17.

Plasma levels of cytokines and soluble cytokine receptors in psychiatric patients upon hospital admission: effects of confounding factors and diagnosis.

Haack M, Hinze-Selch D, Fenzel T, Kraus T, Kühn M, Schuld A, Pollmächer T.

J Psychiatr Res. 1999 Sep-Oct;33(5):407-18.

PMID:
10504009
18.

Cytokines production in chronic schizophrenia patients with or without paranoid behaviour.

Cazzullo CL, Scarone S, Grassi B, Vismara C, Trabattoni D, Clerici M, Clerici M.

Prog Neuropsychopharmacol Biol Psychiatry. 1998 Aug;22(6):947-57.

PMID:
9789879
19.

Immune activation in multiple sclerosis: study of IL-2, sIL-2R, and gamma-IFN levels in serum and cerebrospinal fluid.

Gallo P, Piccinno MG, Pagni S, Argentiero V, Giometto B, Bozza F, Tavolato B.

J Neurol Sci. 1989 Aug;92(1):9-15.

PMID:
2504888
20.

Quantitation of immunosuppression by tacrolimus using flow cytometric analysis of interleukin-2 and interferon-gamma inhibition in CD8(-) and CD8(+) peripheral blood T cells.

Ahmed M, Venkataraman R, Logar AJ, Rao AS, Bartley GP, Robert K, Dodson FS, Shapiro R, Fung JJ, Zeevi A.

Ther Drug Monit. 2001 Aug;23(4):354-62.

PMID:
11477316

Supplemental Content

Support Center